Profile
BIMI ONC INSM WBA HROWL HROWM
Company Name BIMI International Medical Inc. BeOne Medicines Ltd. Insmed Incorporated Walgreens Boots Alliance, Inc. Harrow Health, Inc. 8.625% Senior Notes due 2026 Harrow Health, Inc. 11.875% Senior Notes due 2027
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals Medical - Pharmaceuticals
Market Cap $1.16K $35.50B $30.82B $10.37B $1.37B $1.34B
Employees 0.30K 11.00K 1.27K 193.00K 0.22K 0.22K
CEO Tiewei Song John V. Oyler William H. Lewis Timothy C. Wentworth Mark L. Baum Mark L. Baum
Ratings
BIMI ONC INSM WBA HROWL HROWM
Quant Rating Score 2 2 1 2 1 1
Quant Rating Sell Sell Strong Sell Sell Strong Sell Strong Sell
Trading
BIMI ONC INSM WBA HROWL HROWM
Last Close $0.0001 $332.2 $144.78 $11.98 $25.66 $26.04
High 52 $0.31 $351.13 $147.2 $12.93 $25.71 $27.25
Low 52 - $175.1 $64.81 $8.24 $25.01 $25.85
Price vs. 52 Week High -99.97 % -5.39 % -1.64 % -7.35 % -0.19 % -4.44 %
Price vs. 52 Week Low 0 % 89.72 % 123.39 % 45.39 % 2.6 % 0.74 %
Total Return
BIMI ONC INSM WBA HROWL HROWM
1 Month Return 0 % 4.03 % 13.76 % -0.17 % 0.75 % -1.29 %
3 Month Return -99.71 % 31.42 % 45.57 % 5.18 % 1.09 % -0.99 %
6 Month Return -50 % 27.01 % 88.05 % 7.25 % 1.34 % -2.29 %
9 Month Return -99 % 0 % 106.83 % 23.51 % 2.48 % -0.84 %
YTD Return -90.91 % 80.54 % 109.7 % 28.4 % 1.51 % -0.65 %
1 Year Return -99 % 0 % 98.68 % 32.96 % 0.35 % -2.27 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BIMI ONC INSM WBA HROWL HROWM
Dividend Yield Percentage (TTM) - - - 2.09 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.36 % -35.17 % 0.96 % 0.11 % 0.11 %
Dividend Per Share (TTM) - - - 0.25 % - -
Payout Ratio (TTM) - -7.46 % - -10.29 % - -
Growth
BIMI ONC INSM WBA HROWL HROWM
Asset Growth -6.33 % 1.99 % -16.14 % 24.6 %
Gross Profit Growth -19.62 % 54.71 % -2.02 % 66.06 %
Revenue Growth -44.51 % 54.96 % 6.17 % 53.32 %
Revenue 3 Year 359.09 % 185.46 % 11.65 % 106.71 %
Revenue 5 Year -92.62 % 407.52 % 31.29 % 177.12 %
Revenue 10 Year -94.9 % 14520 % 113.45 % 2980.52 %
EBIT Growth 43.54 % 52.95 % -183.88 % 281.28 %
Net Income Growth 35.99 % 26.87 % -180.39 % 28.39 %
Net Income 3 Yeari Growth Per Share 69.07 % 59.8 % -440.4 % 27.14 %
Net Income 5 Yeari Growth Per Share 24.29 % 61.31 % -331.55 % -7490.95 %
Net Income 10 Yeari Growth Per Share -1116.8 % -1664.38 % -593.61 % 55.74 %
Operating Income Growth -89.19 % 52.95 % -104.53 % 1946.87 %
Operating Cash Flow Growth (CFG) -703.87 % 87.85 % -54.92 % -678.18 %
Operating 3 Year CFG 69.55 % 90.46 % -81.64 % -427.89 %
Operating 5 Year CFG 40.06 % 89.31 % -80.57 % -1760.01 %
Operating 10 Year CFG -108.99 % -709.03 % -71.12 % 19.39 %
EPS Growth 99.74 % 27.57 % -180.39 % 34.67 %
EPS Diluted Growth 99.74 % 27.57 % -180.39 % 34.67 %
Book Value Per Share -90.74 % -6.6 % -57.24 % -9.96 %
Share Holder 3 Year Equity Growth Per Share -97.14 % -52.96 % -56.07 % 363.19 %
Share Holder 5 Year Equity Growth Per Share -99.21 % 94.27 % -53.83 % 78.54 %
Share Holder 10 Year Equity Growth Per Share -99.46 % 6367.84 % -43.9 % 118.93 %
Dividend Per Share Growth - - -24.04 % -
Dividend 3 Year Growth Per Share - - -21.92 % -100 %
Dividend 5 Year Growth Per Share - - -18.12 % -
Dividend 10 Year Growth Per Share - - 16.05 % -
Debt Growth -58.14 % 16.09 % -2.03 % 20.12 %
Free Cash Flow Growth -390.58 % 61.81 % -357.45 % 59.06 %
Updated On 31 Dec 2022 31 Dec 2024 31 Aug 2024 31 Dec 2024
Profitability
BIMI ONC INSM WBA HROWL HROWM
Gross Profit Margin TTM 16.48 % 85.48 % 75.4 % 17.13 % 74.56 % 74.56 %
Return on Assets TTM -62.7 % -3.14 % -41.71 % -9.07 % -2.96 % -2.96 %
Return on Equity TTM -293.85 % -5.64 % -195.37 % -70.17 % -17.5 % -17.5 %
Return on Capital Employed TTM -148.16 % -2.93 % -43.62 % -7.17 % 14.97 % 14.97 %
Net Income Per EBT TTM 103.57 % 241.23 % 100.43 % 109.84 % 95.39 % 95.39 %
EBT Per Ebit TTM 140.97 % 68.65 % 108.89 % 184.02 % -74.47 % -74.47 %
EBIT Per Revenue TTM -129.65 % -2.56 % -237.59 % -2.02 % 6.32 % 6.32 %
Cash Flow To Debt Ratio TTM -187.98 % 55.69 % -146.75 % 5.43 % 1.75 % 1.75 %
Receivables Turnover TTM 2.83 5.3 7.23 23.42 2.88 2.88
Payables Turnover TTM 0.92 1.88 1.32 9.41 2.47 2.47
Inventory Turnover TTM 1.29 1.35 0.91 17.5 5.01 5.01
Fixed Asset Turnover TTM 254.64 % 264.26 % 339.6 % 556.84 % 1951.32 % 1951.32 %
Asset Turnover TTM 33.12 % 74.11 % 16.05 % 222.72 % 65.98 % 65.98 %
Operating Cash Flow Per Share TTM -3.85 40.56 -4.46 1.82 0.11 0.11
Free Cash Flow Per Share TTM -3.85 11.71 -4.59 0.67 -0.93 -0.93
Cash Per Share TTM 87.68 % 19571.94 % 980.85 % 95.96 % 143.96 % 143.96 %
Operating Cash Flow Sales Ratio TTM -86.69 % 12.24 % -212.14 % 1.02 % 1.77 % 1.77 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 28.86 % 102.84 % 36.78 % -851.67 % -851.67 %
Cash Flow Coverage Ratios TTM -187.98 % 55.69 % -146.75 % 5.43 % 1.75 % 1.75 %
Price To Free Cash Flows Ratio TTM - 232.05 -35.48 17.88 -46.08 -42.29
Price To Operating Cash Flows Ratio TTM - 1.09 -32.68 6.57 390.23 358.15
Price Cash Flow Ratio TTM - 1.09 -32.68 6.57 390.23 358.15
Income Statement (TTM)
BIMI ONC INSM WBA HROWL HROWM
Revenue $0.01B $3.81B $0.36B $147.66B $0.2B $0.2B
Gross Profit $0B $3.22B $0.28B $26.52B $0.15B $0.15B
Gross Profit Ratio 16.48% 84.41% 76.43% 17.96% 75.33% 75.33%
EBITDA $-0.02B $-0.4B $-0.81B $-11.28B $0.02B $0.02B
Net Income $-0.02B $-0.64B $-0.91B $-8.64B $-0.02B $-0.02B
EPS Diluted -8.4 -6.12 -5.57 -10.01 -0.49 -0.49
Balance Sheet (MRQ)
BIMI ONC INSM WBA HROWL HROWM
Long Term Debt $0B $0.21B $1.14B $29.88B $0.23B $0.23B
Total Liabilities $0.03B $2.59B $1.74B $68.86B $0.32B $0.32B
Total Equity $0.01B $3.33B $0.29B $12.18B $0.07B $0.07B
Total Investments $0B $0.13B $0.88B $4.06B $0B $0B
Total Debt $0.01B $1.08B $1.15B $32.85B $0.23B $0.23B
Total Assets $0.04B $5.92B $2.03B $81.04B $0.39B $0.39B
Cash Flow Statement (TTM)
BIMI ONC INSM WBA HROWL HROWM
Net Income $-0.02B $-0.64B $-0.91B $-15.45B $-0.02B $-0.02B
Inventory $-0.01B $-0.09B $-0.02B $-0.03B $165B $165B
Dividends Paid $0B $0B $0B $-1.26B $0B $0B
Operating Cash Flow $-0.01B $-0.14B $-0.68B $1.02B $-0.02B $-0.02B
Capital Expenditure $0B $-0.53B $-0.02B $-1.38B $-0.04B $-0.04B
Related Stocks
Ticker Name Price
ATNFW CannBioRx Life Sciences Corp. 0.43
BGMS Bio Green Med Solution, Inc. 4.45
BGMSP Bio Green Med Solution, Inc. 5.61
CGEM Cullinan Oncology, Inc. 6.335
CJJD China Jo-Jo Drugstores, Inc. 1.52
HITI High Tide Inc. 3.98
HROWL Harrow Health, Inc. 8.625% Senior Notes due 2026 25.65
HROWM Harrow Health, Inc. 11.875% Senior Notes due 2027 26.0601
INSM Insmed Incorporated 145.93
LFLY Leafly Holdings, Inc. 37
LFLYW Leafly Holdings, Inc. 0.0041
LFMD LifeMD, Inc. 6.43
LFMDP LifeMD, Inc. 23.77
LITS MEI Pharma, Inc. Common Stock 2.74
MDVL MedAvail Holdings, Inc. 1.8
MEDS TRxADE HEALTH, Inc. 7.59
NEUP 9.51
ONC 343.02
PETS PetMed Express, Inc. 2.78
RAD Rite Aid Corporation 0.6483
Unlock